Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
ACIU AC Immune
- 1.700
- +0.060+3.66%
Close Apr 28 16:00 ET
- 1.700
- 0.0000.00%
Post 16:05 ET
170.70MMarket Cap-2.76P/E (TTM)
1.760High1.650Low245.65KVolume1.650Open1.640Pre Close420.84KTurnover0.60%Turnover RatioLossP/E (Static)100.41MShares4.97852wk High1.26P/B69.81MFloat Cap1.43052wk Low--Dividend TTM41.06MShs Float19.970Historical High--Div YieldTTM6.71%Amplitude1.430Historical Low1.713Avg Price1Lot Size
About AC Immune Company
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Company Profile
SymbolACIU
Company NameAC Immune
Listing DateSep 23, 2016
Issue Price11.00
Founded2003
CEODr. Andrea Pfeifer, PhD
MarketNASDAQ
Employees161
Fiscal Year Ends12-31
AddressEPFL Innovation Park,Building B
CityLausanne
ProvinceVaud
CountrySwitzerland
Zip Code1015
Phone41-21-345-91-21
Websitehttp://www.acimmune.com
Company Executives
- Name
- Position
- Salary
- Dr. Andrea Pfeifer, PhD
- Chief Executive Officer and Director
- --
- Piergiorgio Donati
- Chief Technical Operations Officer
- --
- Howard Donovan
- Chief Human Resources Officer
- --
- Christopher Roberts
- Chief Financial Officer
- --
- Dr. Anke Post, M.D.
- Chief Medical Officer
- --
- Mark Danton
- Executive Vice President, Information Systems and Artificial Intelligence
- --
- Dr. Olivier Sol, M.D.
- Vice President and Head of Clinical Development
- --
- Dr. Matthias Maurer, PhD
- Senior Vice President and General Counsel
- --
- Dr. Julien Rongere, PhD
- Senior Vice President, Regulatory Affairs and Quality Assurance
- --
- Dr. Gunther Staffler, PhD
- Senior Vice President, Immunotherapy
- --
- Dr. Gary Waanders, PhD
- Senior Vice President, Investor Relations and Corporate Communications
- --
- Dr. Francesca Capotosti, PhD
- Vice President, Research
- --
- Dr. Bojana Portmann, PhD
- Vice President, IP and Business Development
- --
- Professor Dr. Monika Butler, PhD
- Vice Chairman of the Board
- --
- Dr. Douglas E. WilliaPhD
- Chairman of the Board
- --
- Professor Dr. Carl June, M.D.
- Independent Director
- --
- Dr. Werner Lanthaler, PhD
- Independent Director
- --
- Dr. Roy Twyman, M.D.
- Independent Director
- --
- Dr. Monica Shaw, M.D.
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
